SUMMARY Two patients with combined cerebellar and Parkinsonian features consistent with olivopontocerebellar degeneration were treated with long term oral L-dopa. Both patients showed improvement of the Parkinsonian symptoms but the cerebellar symptoms were unchanged. It is suggested that the Parkinsonian manifestations of this syndrome are related to loss of dopamine in the striatum secondary to lesions of the substantia nigra. It is suggested that other patients with similar disorders should be given a trial with L-dopa.
familial form of degeneration with onset between the ages of 20 to 30, while they had described a sporadic form with onset at a later age. Since the original description of this disease, other investigators have described hereditary forms of olivopontocerebellar degeneration. Keiller (1926) described four cases of olivopontocerebellar degeneration who had positive hereditary histories. Three of these cases were verified on post-mortem examination. Yang, Ling, and Chang (1938) have reported the familial occurrence of this disease over five generations. Many other cases have been reported since then with and without pathological verification. Brown (1962) has concluded that many of the cases in the literature reported to be 'Marie's hereditary ataxia' are actually olivopontocerebellar degeneration. It appears that, contrary to the original description, olivopontocerebellar degeneration is frequently hereditary and, in fact, is one of the spinocerebellar degenerations in which familial occurrence is common. The current concept of the pathology of olivopontocerebellar degeneration has been outlined by Brown (1962) who describes diminution in the size of the pons, medulla, and cerebellum with extensive degeneration of the inferior olives and basal pontine nuclei with secondary gliosis. He also describes demyelinization of the cerebellar white matter with degeneration of Purkinje and ganglion cells. Critchley and Greenfield (1948) have described a 'tendency towards degeneration of other nuclei andfibre tracts subserving movement, but not directly connected with the cerebellum, e.g. dorsal columns and pyramidal tracts, substantia nigra, corpus luysii, and lenticular nucleus.' The findings of nigral and basal ganglia involvement in olivopontocerebellar degeneration, although not universally present, have been reported frequently. Scherer (1933) in his report of four instances of olivopontocerebellar degeneration noted regular changes in the substantia nigra and basal ganglia. These included marked depigmentation of the substantia nigra which he related to a 'local presenile aging process'. Lambie, Latham, and McDonald (1947) have reported significant involvement of the substantia nigra, caudate, putamen, and globus pallidus, as well as the regular features of olivopontocerebellar degeneration. Jellinger (1968) has reported a series of 15 cases of olivopontocerebellar degeneration in which there was frequent involvement of the substantia nigra. He described striatal degeneration including severe demyelinizition of the putamen with complete loss of large neurones and dense gliosis associatedwithminor damage to the pallidum as well as involvement of the reticular zone of the substantia nigra.
From these studies of post-mortem material it appears that the substantia nigra and areas of the basal ganglia are frequently involved. Since alterations of the substantia nigra are felt to be the single most important lesion in the production of Parkinsonism (Greenfield and Bosanquet, 1953; Klawans, Ilahi, and Shenker, 1970) , it would not be surprising if some patients with olivopontocerebellar degeneration had Parkinsonian features. Extrapyramidal symptoms have been described in numerous patients. Dejerine and Thomas (1900) as well as Marie (1893) mentioned rigidity as one of the minor symptoms of the syndrome. Von Stauffenberg (1918) reported extrapyramidal symptoms in his case report of olivopontocerebellar degeneration. Scherer (1933) (Ley, 1924; Guillain, Mathieu, and Bertrand, 1926; Guillain, Thdvenard, and Jonesco, 1928; Guillain and Thevenard, 1931 A 55-year-old white female was in good health until age 46 when she noted the onset of tremor in her right leg. At that time she was told that she had Parkinsonism. The tremor was relatively non-progressive until the age of 53, but since then she has had progressive tremor of both upper extremities and difficulty in walking. The tremor was characterized by the patient as being present both at rest and on intention. She felt that it was more marked in the right than in the left upper extremity, but was equal in the lower extremities.
In addition, the patient has noticed a problem with walking and with balance. This began with difficulty in walking in high heels but for the last two years her gait difficulty has been increasing. She There was a rest tremor of the lower extremities of equal intensity. The patient had gross titubation and truncal ataxia with inability to stand or sit without tending to fall.
Her stance was wide based even with support. She was unable to tolerate a narrow base. There was no response on the part of the patient to a backward push on the sternum (absence of postural reflex). Movements were slow and there was slowness in both initiating and carrying out gross movements such as getting out of a chair. Finger dexterity was slowed bilaterally as were all rapid alternating movements. Glabellar, palmomental, and Babinski reflexes were elicited bilaterally but snout or suck reflexes could not be obtained. Deep tendon reflexes were active and equal. There was no weakness or atrophy and sensation was within normal limits.
The patient was admitted to the hospital and a pneumoencephalogram was done which was normal. The spinal fluid contained no cells. The protein content was 37 mg/100 ml. The homovanillic acid level was 11 ng/ml. The patient was continued on her regular medications and then started on L-dopa as outlined by Klawans and Garvin (1969) . She reached a maintenance dosage of 4 g daily and showed progressive improvement over several months. After one month on L-dopa the patient was able to sit and stand without support. Detailed evaluation after six months of L-dopa therapy revealed that she walked with a wide base and was still unable to tolerate a narrow base. Her postural reflexes were normal and she had not fallen in several months. She was now walking both inside the house and outside by herself. She had not done the latter for over one year before taking L-dopa. Her face now demonstrated only minimal hypomimia. The rest tremor was markedly improved but the titubation and intention tremor were unchanged. The Babinski and palmomental reflexes persisted but the glabellar reflex could no longer be elicited. There was no slowness apparent on gross movements although fine movements remained slow.
COMMENT It was our initial impression that this patient had a familial degenerative disease with both Parkinsonian and cerebellar features. Her major disability was related to her marked difficulty with balance. While some of this was felt to be related to her cerebellar deficit, it was felt that the loss of postural reflexes might contribute to this problem. She was placed on L-dopa and regained normal postural reflexes and marked improvement in gait and balance. The Parkinsonian features improved dramatically on L-dopa, while the cerebellar deficits remained unchanged.
CASE 2
A 64-year-old white male was in good health until aged 60 when he noted progressive slowness and difficulty in initiating and carrying out movements. This involved all four extremities and was associated with a feeling of stiffness in his neck, arms, and legs. Over the past two years he has noted difficulty in balance and has felt unsteady while walking. He also has noted tremor of both hands. The tremor was present at rest as well as during activities such as eating. Over the last year he developed progressive speech difficulty. He had been on trihexyphenidyl 2 mg three times a day and was recently placed on amantadine hydrochloride without any apparent improvement. The patient stated that his father had had progressive stiffness and walking difficulty beginning sometime late in life but he was unaware of any other family members with similar difficulty.
General 
DISCUSSION
The most significant lesion in Parkinsonism is degeneration of the cell bodies of the substantia nigra (Forno, 1966; Greenfield and Bosanquet, 1953) . This cell loss results in degeneration of the nigrostriatal pathway (Anden, Carlsson, Dahlstr6m, Fuxe, Hillarp, and Larsson, 1964; Anddn, Dahlstrom, Fuxe, and Larsson, 1965 ) with a subsequent loss of the normal dopaminergic input to the striatum (Hornykiewicz, 1966) . It has been suggested that this loss of dopaminergic influence on the striatal neurones is the most significant factor in the production of all of the symptoms of Parkinsonism (Klawans, Ilahi, and Shenker, 1970) . L-dopa (L,3,4 dihydroxyphenylalanine) is the normal precursor of dopamine. It is decarboxylated to form dopamine by dopa decarboxylase. Dopamine is said to be a neurotransmitter and is thought to inhibit the neurones of the striatum (MacLennan and York, 1967) . It has been suggested that the effectiveness of L-dopa in Parkinsonism derives from a reinstitution of dopamine inhibition of the striatal neurones (Barbeau, 1962; Hornykiewicz, 1966) . This is said to be a result of the action of dopamine at striatal dopamine receptors. If this is true, L-dopa would not influence symptoms which are not related to decreased or altered dopaminergic influence on striatal neurones (Klawans, 1968) . There are, however, no detailed reports on the results of long-term L-dopa therapy in patients with symptoms unrelated to basal ganglia dysfunction. The results of the use of L-dopa in the two patients presented here support the concept that L-dopa acts specifically on symptoms related to lesions of the dopaminergic system.
Both patients had combined cerebellar and Parkinsonian features. Each also had bilateral Babinski signs indicating coexisting pyramidal tract involvement. Both gave a history of other family members with similar involvement. In the first patient there is a history of involvement in many members over three generations, while in the second patient there is only a history of similar disease in the father. As outlined above, it was felt that the patients had olivopontocerebellar degeneration. The occurrence of reportedly similar problems in other family members is felt to support this diagnosis. The diagnosis of olivopontocerebellar degeneration implies that there is involvement of the nigrostriatal neurones of the substantia nigra as part of the disease process. This involvement can be identical with the alterations seen in Parkinsonism (Greenfield and Bosanquet, 1953) . The assumption that these two patients had lesions of the substantia nigra is of practical significance, since the symptoms resulting from such a lesion are usually improved by L-dopa.
A definite diagnosis of olivopontocerebellar degeneration can only be made on the basis of necropsy material. However, from a practical stand-point, the degree of involvement of the nigrostriatal system can be estimated by measuring spinal fluid homovanillic acid. Homovanillic acid is the major catabolic product of dopamine. Its concentration within the cerebrospinal fluid is a reflection of dopamine metabolism within the central nervous system (Bartholini, Pletscher, and Tissot, 1966; Pletscher, Bartholini, and Tissot, 1967) . Spinal fluid homovanillic acid levels are decreased in Parkinsonism (Bernheimer, Birkmayer, and Hornykiewicz, 1966) . This is felt to reflect the decreased dopamine concentration found in the striatum and substantia nigra of these patients. Spinal fluid homovanillic acids increase greatly after L-dopa therapy and this increase is felt to reflect increased utilization of dopamine within the central nervous system (Weiner, Harrison, and Klawans, 1969) .
Spinal fluid homovanillic acid levels were estimated in both patients before the institution of L-dopa. It was significantly decreased in both patients. The range in normal subjects and patients without Parkinsonism has been shown to range from 30 to 100 ng/ml. (Anden, Roos, and Werdinius, 1963) . Barolin and Hornykiewicz (1967) consider 35 ng/ml. to be the lower limit of normal. The spinal fluid homovanillic acid level in case 1 was 11 ng/ml., while in case 2 it was 7 ng/ml. These decreased values were interpreted as suggesting that there was decreased dopamine utilization in both patients as a reflection of involvement of the nigrostriatal dopaminergic neuronal system. While decreased levels of homovanillic acid have been reported in conditions other than Parkinsonism (Barolin and Hornykiewicz, 1967) , levels as low as these reported here have been seen only in Parkinsonism or meningoencephalitis. Neither of the patients reported had cells in the spinal fluid or other evidence of inflammatory disease.
Lesions of the striatum itself and of the pallidum which have been reported in olivopontocerebellar degeneration could perhaps contribute to the extrapyramidal featu'res in these patients. If L-dopa acts as dopamine at the striatal dopamine receptors then symptoms due to striatal or pallidal lesions might not improve on L-dopa (Klawans and Erlich, 1969; Klawans,Ilahi,'and Shenker, 1970) .
-Lesions of the striatum or pallidum would probably not account for decreased levels of spinal fluid homovanillic acid, s'ince the dopamire metabolism is' controlled by the cells of the substantia nigra-not those of the striatum or pallidum (Anden et al., 1964 (Anden et al., , 1965 . It was felt'that the depressed levels of homovanillic acid in these two patients suggested that lesions of the substantia nigra were significant and that L-dopa might be of some use. While 'this conclusion was obvious in the second patient whose clinical condition was dominated by the symptoms of Parkinsonism, it was not as obvious in case 1 in whom ataxia appeared to be the dominant problem.
Both patients showed definite amelioration of their Parkinsonian symptoms from long-term oral L-dopa therapy. This is consistent with attributing the Parkinsonian manifestations to lesions of the substantia nigra and subsequent dopaminergic denervation of the striatum. This supports the view of Scherer (1933) , who attributed the Parkinsonian features of olivopontocerebellar degeneration to lesions of the substantia nigra.
While both patients improved on L-dopa, the improvement in case 1 is of greater interest. This patient was totally disabled because of her inability to sit or stand without support. She had titubation and ataxia as well as absent postural reflexes. It was difficult to tell to what degree cerebellar ataxia and Parkinsonian loss of postural reflexes were contributing to her inability to stand. Because of the frequent improvement of postural reflexes by L-dopa, as initially pointed out by Klawans and Erlich (1969) , the patient was placed on L-dopa. Her improvement was dramatic and, although she remains ataxic, she is now able to care for herself and carry on an active life.
The experience with L-dopa in this patient suggests that, in patients with combined cerebellar and Parkinsonian syndromes, a major part of the gait disability may be related to loss of postural reflexes. Since this frequently responds to long-term oral L-dopa therapy such patients should be given a trial of this drug.
The cerebellar symptoms of ataxia, intention tremor, and titubation were unaltered in these two patients. Since some patients with Parkinsonism have shown initial improvement on L-dopa only after three to six months of oral therapy (GodwinAusten, Tomlinson, Frears, and Kok, 1969) , it should be noted that both these patients have been on L-dopa for over six months without any change in cerebellar symptoms. The clear differentiation in response of the Parkinsonism and cerebellar symptoms suggests that the pathogenesis of the two types of symptoms is different, even though the aetiological basis is probably identical. The cellular alterations of the cerebellar system and nigrostriatal system in both patients are hereditary. While it is possible that the basic genetic defect may differ from family to family, it is most probable that the primary neuronal defect in any one family is the same in all the involved neurones. The same genetic lesion involves the pigmented cells of the substantia nigra as the cells of the cerebellum and perhaps of the olives and pons. Only the defect related to the lesion of the substantia nigra is reversible by L-dopa. This is because the lesions of the substantia nigra result in a loss of dopamine input into the striatum which can be reversed by L-dopa.
